Skin Cancer Therapeutics Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Skin Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Skin Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Skin Cancer Therapeutics Overall Market Size
2.1 Global Skin Cancer Therapeutics Market Size: 2021 VS 2027
2.2 Global Skin Cancer Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Skin Cancer Therapeutics Players in Global Market
3.2 Top Global Skin Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Skin Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Skin Cancer Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Skin Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Skin Cancer Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Skin Cancer Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Skin Cancer Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Skin Cancer Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Chemotherapy
4.1.3 Radiotherapy
4.1.4 Cryosurgery
4.1.5 Immune Therapy
4.1.6 Photodynamic Therapy
4.1.7 Surgery
4.1.8 Other Treatments
4.2 By Type - Global Skin Cancer Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Skin Cancer Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global Skin Cancer Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global Skin Cancer Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Skin Cancer Therapeutics Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Cancer Research Center
5.1.5 Others
5.2 By Application - Global Skin Cancer Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Skin Cancer Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global Skin Cancer Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global Skin Cancer Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Skin Cancer Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Skin Cancer Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Skin Cancer Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global Skin Cancer Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global Skin Cancer Therapeutics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Skin Cancer Therapeutics Revenue, 2016-2027
6.3.2 US Skin Cancer Therapeutics Market Size, 2016-2027
6.3.3 Canada Skin Cancer Therapeutics Market Size, 2016-2027
6.3.4 Mexico Skin Cancer Therapeutics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Skin Cancer Therapeutics Revenue, 2016-2027
6.4.2 Germany Skin Cancer Therapeutics Market Size, 2016-2027
6.4.3 France Skin Cancer Therapeutics Market Size, 2016-2027
6.4.4 U.K. Skin Cancer Therapeutics Market Size, 2016-2027
6.4.5 Italy Skin Cancer Therapeutics Market Size, 2016-2027
6.4.6 Russia Skin Cancer Therapeutics Market Size, 2016-2027
6.4.7 Nordic Countries Skin Cancer Therapeutics Market Size, 2016-2027
6.4.8 Benelux Skin Cancer Therapeutics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Skin Cancer Therapeutics Revenue, 2016-2027
6.5.2 China Skin Cancer Therapeutics Market Size, 2016-2027
6.5.3 Japan Skin Cancer Therapeutics Market Size, 2016-2027
6.5.4 South Korea Skin Cancer Therapeutics Market Size, 2016-2027
6.5.5 Southeast Asia Skin Cancer Therapeutics Market Size, 2016-2027
6.5.6 India Skin Cancer Therapeutics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Skin Cancer Therapeutics Revenue, 2016-2027
6.6.2 Brazil Skin Cancer Therapeutics Market Size, 2016-2027
6.6.3 Argentina Skin Cancer Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Skin Cancer Therapeutics Revenue, 2016-2027
6.7.2 Turkey Skin Cancer Therapeutics Market Size, 2016-2027
6.7.3 Israel Skin Cancer Therapeutics Market Size, 2016-2027
6.7.4 Saudi Arabia Skin Cancer Therapeutics Market Size, 2016-2027
6.7.5 UAE Skin Cancer Therapeutics Market Size, 2016-2027
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Skin Cancer Therapeutics Major Product Offerings
7.1.4 Pfizer Skin Cancer Therapeutics Revenue in Global (2016-2021)
7.1.5 Pfizer Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Skin Cancer Therapeutics Major Product Offerings
7.2.4 Merck Skin Cancer Therapeutics Revenue in Global (2016-2021)
7.2.5 Merck Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Skin Cancer Therapeutics Major Product Offerings
7.3.4 Novartis Skin Cancer Therapeutics Revenue in Global (2016-2021)
7.3.5 Novartis Key News
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Corporate Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Skin Cancer Therapeutics Major Product Offerings
7.4.4 GlaxoSmithKline Skin Cancer Therapeutics Revenue in Global (2016-2021)
7.4.5 GlaxoSmithKline Key News
7.5 Bristol Myers Squibb
7.5.1 Bristol Myers Squibb Corporate Summary
7.5.2 Bristol Myers Squibb Business Overview
7.5.3 Bristol Myers Squibb Skin Cancer Therapeutics Major Product Offerings
7.5.4 Bristol Myers Squibb Skin Cancer Therapeutics Revenue in Global (2016-2021)
7.5.5 Bristol Myers Squibb Key News
7.6 Eli Lilly
7.6.1 Eli Lilly Corporate Summary
7.6.2 Eli Lilly Business Overview
7.6.3 Eli Lilly Skin Cancer Therapeutics Major Product Offerings
7.6.4 Eli Lilly Skin Cancer Therapeutics Revenue in Global (2016-2021)
7.6.5 Eli Lilly Key News
7.7 Roche
7.7.1 Roche Corporate Summary
7.7.2 Roche Business Overview
7.7.3 Roche Skin Cancer Therapeutics Major Product Offerings
7.4.4 Roche Skin Cancer Therapeutics Revenue in Global (2016-2021)
7.7.5 Roche Key News
7.8 Qiagen
7.8.1 Qiagen Corporate Summary
7.8.2 Qiagen Business Overview
7.8.3 Qiagen Skin Cancer Therapeutics Major Product Offerings
7.8.4 Qiagen Skin Cancer Therapeutics Revenue in Global (2016-2021)
7.8.5 Qiagen Key News
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Corporate Summary
7.9.2 Boehringer Ingelheim Business Overview
7.9.3 Boehringer Ingelheim Skin Cancer Therapeutics Major Product Offerings
7.9.4 Boehringer Ingelheim Skin Cancer Therapeutics Revenue in Global (2016-2021)
7.9.5 Boehringer Ingelheim Key News
7.10 Aqua Pharmaceuticals
7.10.1 Aqua Pharmaceuticals Corporate Summary
7.10.2 Aqua Pharmaceuticals Business Overview
7.10.3 Aqua Pharmaceuticals Skin Cancer Therapeutics Major Product Offerings
7.10.4 Aqua Pharmaceuticals Skin Cancer Therapeutics Revenue in Global (2016-2021)
7.10.5 Aqua Pharmaceuticals Key News
7.11 Meda
7.11.1 Meda Corporate Summary
7.11.2 Meda Business Overview
7.11.3 Meda Skin Cancer Therapeutics Major Product Offerings
7.11.4 Meda Skin Cancer Therapeutics Revenue in Global (2016-2021)
7.11.5 Meda Key News
7.12 Elekta AB
7.12.1 Elekta AB Corporate Summary
7.12.2 Elekta AB Business Overview
7.12.3 Elekta AB Skin Cancer Therapeutics Major Product Offerings
7.12.4 Elekta AB Skin Cancer Therapeutics Revenue in Global (2016-2021)
7.12.5 Elekta AB Key News
7.13 Varian Medical Systems
7.13.1 Varian Medical Systems Corporate Summary
7.13.2 Varian Medical Systems Business Overview
7.13.3 Varian Medical Systems Skin Cancer Therapeutics Major Product Offerings
7.13.4 Varian Medical Systems Skin Cancer Therapeutics Revenue in Global (2016-2021)
7.13.5 Varian Medical Systems Key News
7.14 Bausch Health
7.14.1 Bausch Health Corporate Summary
7.14.2 Bausch Health Business Overview
7.14.3 Bausch Health Skin Cancer Therapeutics Major Product Offerings
7.14.4 Bausch Health Skin Cancer Therapeutics Revenue in Global (2016-2021)
7.14.5 Bausch Health Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Skin Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Skin Cancer Therapeutics Market Drivers in Global Market
Table 3. Skin Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Skin Cancer Therapeutics in Global Market
Table 5. Top Skin Cancer Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Skin Cancer Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Skin Cancer Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Skin Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Skin Cancer Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Skin Cancer Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Skin Cancer Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Skin Cancer Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Skin Cancer Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Skin Cancer Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Skin Cancer Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Skin Cancer Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Skin Cancer Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Skin Cancer Therapeutics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Skin Cancer Therapeutics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Skin Cancer Therapeutics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Skin Cancer Therapeutics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Skin Cancer Therapeutics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Skin Cancer Therapeutics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Skin Cancer Therapeutics Revenue, (US$, Mn), 2022-2027
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Skin Cancer Therapeutics Product Offerings
Table 32. Pfizer Skin Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 33. Merck Corporate Summary
Table 34. Merck Skin Cancer Therapeutics Product Offerings
Table 35. Merck Skin Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 36. Novartis Corporate Summary
Table 37. Novartis Skin Cancer Therapeutics Product Offerings
Table 38. Novartis Skin Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 39. GlaxoSmithKline Corporate Summary
Table 40. GlaxoSmithKline Skin Cancer Therapeutics Product Offerings
Table 41. GlaxoSmithKline Skin Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 42. Bristol Myers Squibb Corporate Summary
Table 43. Bristol Myers Squibb Skin Cancer Therapeutics Product Offerings
Table 44. Bristol Myers Squibb Skin Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 45. Eli Lilly Corporate Summary
Table 46. Eli Lilly Skin Cancer Therapeutics Product Offerings
Table 47. Eli Lilly Skin Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 48. Roche Corporate Summary
Table 49. Roche Skin Cancer Therapeutics Product Offerings
Table 50. Roche Skin Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 51. Qiagen Corporate Summary
Table 52. Qiagen Skin Cancer Therapeutics Product Offerings
Table 53. Qiagen Skin Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 54. Boehringer Ingelheim Corporate Summary
Table 55. Boehringer Ingelheim Skin Cancer Therapeutics Product Offerings
Table 56. Boehringer Ingelheim Skin Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 57. Aqua Pharmaceuticals Corporate Summary
Table 58. Aqua Pharmaceuticals Skin Cancer Therapeutics Product Offerings
Table 59. Aqua Pharmaceuticals Skin Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 60. Meda Corporate Summary
Table 61. Meda Skin Cancer Therapeutics Product Offerings
Table 62. Meda Skin Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 63. Elekta AB Corporate Summary
Table 64. Elekta AB Skin Cancer Therapeutics Product Offerings
Table 65. Elekta AB Skin Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 66. Varian Medical Systems Corporate Summary
Table 67. Varian Medical Systems Skin Cancer Therapeutics Product Offerings
Table 68. Varian Medical Systems Skin Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 69. Bausch Health Corporate Summary
Table 70. Bausch Health Skin Cancer Therapeutics Product Offerings
Table 71. Bausch Health Skin Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Skin Cancer Therapeutics Segment by Type
Figure 2. Skin Cancer Therapeutics Segment by Application
Figure 3. Global Skin Cancer Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Skin Cancer Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Skin Cancer Therapeutics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Skin Cancer Therapeutics Revenue in 2020
Figure 8. By Type - Global Skin Cancer Therapeutics Revenue Market Share, 2016-2027
Figure 9. By Application - Global Skin Cancer Therapeutics Revenue Market Share, 2016-2027
Figure 10. By Region - Global Skin Cancer Therapeutics Revenue Market Share, 2016-2027
Figure 11. By Country - North America Skin Cancer Therapeutics Revenue Market Share, 2016-2027
Figure 12. US Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Skin Cancer Therapeutics Revenue Market Share, 2016-2027
Figure 16. Germany Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 17. France Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Skin Cancer Therapeutics Revenue Market Share, 2016-2027
Figure 24. China Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 28. India Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Skin Cancer Therapeutics Revenue Market Share, 2016-2027
Figure 30. Brazil Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Skin Cancer Therapeutics Revenue Market Share, 2016-2027
Figure 33. Turkey Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Skin Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 37. Pfizer Skin Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Merck Skin Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Novartis Skin Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. GlaxoSmithKline Skin Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Bristol Myers Squibb Skin Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Eli Lilly Skin Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Roche Skin Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Qiagen Skin Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Boehringer Ingelheim Skin Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Aqua Pharmaceuticals Skin Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Meda Skin Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Elekta AB Skin Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Varian Medical Systems Skin Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Bausch Health Skin Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Pfizer
Merck
Novartis
GlaxoSmithKline
Bristol Myers Squibb
Eli Lilly
Roche
Qiagen
Boehringer Ingelheim
Aqua Pharmaceuticals
Meda
Elekta AB
Varian Medical Systems
Bausch Health